Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction

Published:2020-04 Issue:4 Volume:8 Page:329-340
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Teerlink John R.,Diaz Rafael,Felker G. Michael,McMurray John J.V.,Metra Marco,Solomon Scott D.,Legg Jason C.,Büchele Gustavo,Varin Claire,Kurtz Christopher E.,Malik Fady I.,Honarpour Narimon

Funder

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Direct myosin activation by omecamtiv mecarbil for heart failure with reduced ejection fraction;Psotka;Handb Exp Pharmacol,2017

2. Heart failure;Metra;Lancet,2017

3. Cardiac calcitropes, myotropes, and mitotropes: JACC Review Topic of the Week;Psotka;J Am Coll Cardiol,2019

4. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure;Malik;Science,2011

5. Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin;Morgan;ACS Med Chem Lett,2010

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between cardiac time intervals and incident heart failure after acute coronary syndrome;The International Journal of Cardiovascular Imaging;2024-08-03

2. Efficacy and Safety of Omecamtiv Mecarbil in Adult Patients with Heart Failure with Reduced Ejection Fraction;International Journal of Pharmacology;2024-08-01

3. Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium;Heart Failure Reviews;2024-06-29

4. Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models;Journal of Clinical Investigation;2024-06-17

5. Heart Failure With Improved Ejection Fraction: Prevalence, Predictors, and Guideline-Directed Medical Therapy;Cureus;2024-06-06